EnglishThe board of administration of Braşov-based drug distributor "Ropharma" has summoned the General Shareholders" meeting in Iaşi, on April 15th. Shareholders will need to approve last year"s financial statements as well as set the revenue and expense budget for the current year.
The shareholders of "Ropharma" Braşov have approved the allocation 0.21% of the company"s stock to employees and management, as bonus for their activity and the list of employees that will receive the 271,066 shares allocated as part of this program.
The shares which will be distributed free of charge were bought back from the stock market in Q2 2009, to be distributed to employees as part of the employee loyalty program. The company has a share capital of 12.6 million lei, divided into 126.5 million shares with a face value of 0.1 lei.
"Ropharma" is controlled by two companies registered in Cyprus, "ADD Pharmaceuticals" and "Rimia Investments", which own 23.4% and 26.6% of its shares. Other shareholders include "Arrow Pharmaceuticals", a company incorporated in the USA, which owns 31.31%, whereas the Authority for State Assets Recovery (AVAS) owns 0.33%.
Euro
Dolar SUA
Franc elveţian
Liră sterlină
Gram de aur
